Lifespan Cancer Institute - Rhode Island Hospital — Providence, Rhode Island

Lifespan Cancer Institute - Rhode Island Hospital is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Lifespan Cancer Institute - Rhode Island Hospital has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Cancer Harboring BRAF Alterations.

Sponsors: Mirati Therapeutics Inc., Fore Biotherapeutics.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lifespan Cancer Institute - Rhode Island Hospital?

Lifespan Cancer Institute - Rhode Island Hospital has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lifespan Cancer Institute - Rhode Island Hospital conducted?

Lifespan Cancer Institute - Rhode Island Hospital has 2 clinical trials on record, with 2 currently active. Their work covers Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Cancer Harboring BRAF Alterations.

Is Lifespan Cancer Institute - Rhode Island Hospital accredited by Crixeo Health?

Lifespan Cancer Institute - Rhode Island Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lifespan Cancer Institute - Rhode Island Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.